RBC Capital Starts Sagent Pharmaceuticals (SGNT) at Outperform
Tweet
Share
E-mailGet Alerts SGNT Hot Sheet
Price: $21.76 --0%
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Join SI Premium – FREE
RBC Capital initiates coverage on Sagent Pharmaceuticals (NASDAQ: SGNT) with an Outperform. PT $29.
For more ratings news on Sagent Pharmaceuticals click here and for the rating history of Sagent Pharmaceuticals click here.
Shares of Sagent Pharmaceuticals closed at $25.21 yesterday.
For more ratings news on Sagent Pharmaceuticals click here and for the rating history of Sagent Pharmaceuticals click here.
Shares of Sagent Pharmaceuticals closed at $25.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Assumes Life360 Inc (360:AU) at Outperform
- Hovde Group Starts First Carolina Financial Services (FCBM) at Market Perform
- CLSA Starts Delta Electronics Thailand PCL (DELTA:TB) at High-Conviction Outperform (1)
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
